5′CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer

This publication has 14 references indexed in Scilit:

• The tumor spectrum in FHIT- deficient mice
  Proceedings of the National Academy of Sciences, 2001
• FHIT gene therapy prevents tumor development in Fhit-deficient mice
  Proceedings of the National Academy of Sciences, 2001
• Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non‐small cell lung carcinomas (NSCLCs)
  The Journal of Pathology, 2000
• Cancer-specific chromosome alterations in the constitutive fragile region FRA3 B
  Proceedings of the National Academy of Sciences, 1999
• THE ROLE OF THE FHIT/FRA3B LOCUS IN CANCER
  Annual Review of Genetics, 1998
• Expression of abnormal transcripts of the FHIT (Fragile Histidine Triad) gene in ovarian carcinoma
  European Journal Of Cancer, 1998
• Protein Expression and Functional Analysis of the FHIT Gene in Human Tumor Cells
  JNCI Journal of the National Cancer Institute, 1998
• Tumor Suppressor Genes: Does FHIT Fit?
  JNCI Journal of the National Cancer Institute, 1998
• The FHIT Gene at 3p14.2 Is Abnormal in Lung Cancer
  Cell, 1996
• The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers
  Cell, 1996